Bambuterol
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391705This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y1850G1OVC. European Medicines Agency schedules Bambuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06095MIG. Bambuterol generally arises in the molecular formula C18H29N3O5. The term BAMBUTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) BAMBUTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bambuterol under HS 29242995 and SITC 51479. As of Q4 2014, BAMBUTEROL remains the US FDA Preferred Term for this commodity. Bambuterol bears US NLM identifiers UMLS ID C0052944 and NCI Concept Code C81692. SMILES: OC(CNC(C)(C)C)C1CC(OC(=O)N(C)C)CC(OC(=O)N(C)C)C1.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.